Singapore markets closed

Organogenesis Holdings Inc. (ORGO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
16.66+0.92 (+5.84%)
At close: 4:00PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 52.14B
Enterprise value 32.16B
Trailing P/E 29.75
Forward P/E 136.22
PEG Ratio (5 yr expected) 10.71
Price/sales (ttm)4.94
Price/book (mrq)11.94
Enterprise value/revenue 34.99
Enterprise value/EBITDA 724.25

Trading information

Stock price history

Beta (5Y monthly) 1.72
52-week change 3332.73%
S&P500 52-week change 335.11%
52-week high 324.34
52-week low 33.36
50-day moving average 315.44
200-day moving average 317.26

Share statistics

Avg vol (3-month) 3959.28k
Avg vol (10-day) 31.73M
Shares outstanding 5128.58M
Implied shares outstanding 6N/A
Float 46.04M
% held by insiders 151.39%
% held by institutions 139.17%
Shares short (30 Aug 2021) 46.21M
Short ratio (30 Aug 2021) 410.05
Short % of float (30 Aug 2021) 49.71%
Short % of shares outstanding (30 Aug 2021) 44.83%
Shares short (prior month 29 Jul 2021) 46.69M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Jun 2021

Profitability

Profit margin 16.17%
Operating margin (ttm)18.59%

Management effectiveness

Return on assets (ttm)17.61%
Return on equity (ttm)65.27%

Income statement

Revenue (ttm)433.35M
Revenue per share (ttm)3.63
Quarterly revenue growth (yoy)78.60%
Gross profit (ttm)250.98M
EBITDA 89.18M
Net income avi to common (ttm)70.06M
Diluted EPS (ttm)0.56
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)91.59M
Total cash per share (mrq)0.71
Total debt (mrq)112.2M
Total debt/equity (mrq)62.71
Current ratio (mrq)2.39
Book value per share (mrq)1.39

Cash flow statement

Operating cash flow (ttm)49.6M
Levered free cash flow (ttm)-4.64M